Has Anupama Kumar, MD received payments from drug or device companies?

Yes. Drug and device makers reported $14,692 in general payments to Anupama Kumar, MD across 21 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Anupama Kumar, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Anupama Kumar, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Anupama Kumar, MD

Internal Medicine · la Jolla, CANPI 1164879656

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $13,538 of the $14,692 with a category attached, or 92.1%. Janssen Global Services, LLC accounts for 66.5% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $14,354, more than ten times the $91 reported in 2021. Among internal medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,692in general payments, 2019–2025

Across 21 payments — averaging $699.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Janssen Global Services, LLC$10K
Astrazeneca UK Limited$2K
Legend Biotech USA Inc.$2K
Johnson & Johnson$330
AstraZeneca$195
Foundation Medicine, Inc.$124
plus $121 from 2 others

$530,791in research payments, 2019–2025

Across 8 payments — averaging $66,349 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Bristol Myers Squibb$374K
Janssen Research & Development, LLC$114K
AstraZeneca$44K

What the payments were for

Consulting fees$13,53892%
Travel & lodging$720%
Food & beverage$1,0827%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Janssen Global Services, LLC	6	$9,768
Astrazeneca UK Limited	2	$2,355
Legend Biotech USA Inc.	4	$1,799
Johnson & Johnson	4	$330
AstraZeneca	2	$195
Foundation Medicine, Inc.	1	$124
Sanofi	1	$91
Pfizer	1	$30

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,692 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California →

Medicare billing

Part B allowed, 2024

$176,206

Medicare patients

146

Services billed

4,600

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
RevlimidLenalidomide	83	$1,507,747
PomalystPomalidomide	49	$1,016,314
NinlaroIxazomib Citrate	12	$155,394
Atovaquone	11	$6,001
Entecavir	12	$5,186
Acyclovir	65	$1,568
Oxycodone Hcl	30	$487
Omeprazole	12	$222
Ondansetron OdtOndansetron	12	$221
Gabapentin	11	$186
Allopurinol	22	$162
Tramadol Hcl	12	$123
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	16	$64
Lorazepam	11	$60

Paid to pharmacies, not to this prescriber.

Other internal medicine in la Jolla

Hyong Kimla Jolla$1M
Rohit Loombala Jolla$965K
Fouad Moawadla Jolla$725K
Lewis Rubinla Jolla$265K
Andrew ChengSouth San Francisco$55.1M
Tung NgoNewport Beach$4.9M
Christian EversullStanford$2.9M
Christian SandrockSacramento$2.1M
Hatim HusainSan Diego$2M
Teck LingPalo Alto$1.1M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →